UnitedHealth (UNH) Director Files Form 4 Showing 1,248 Indirect Shares

Rhea-AI Filing Summary

Charles D. Baker, a director of UnitedHealth Group Inc. (UNH), filed a Form 4 reporting changes in his beneficial ownership. The filing shows a transaction dated 09/11/2025 reporting 27 shares of Common Stock with transaction code S at a price of $356.05. The Form reports that following the reported transaction the reporting person had 1,248 shares of Common Stock beneficially owned indirectly (by trust). The form also explains that on 08/01/2025 the reporting person acquired indirect beneficial ownership of 27 UNH shares by inheritance, an acquisition the filer states was exempt from reporting under Rules 16a-3 and 16b-5.

Insights

Financial Analyst

TL;DR: Director reported a small sale and retains indirect ownership of 1,248 UNH shares; transaction appears immaterial to company fundamentals.

The Form 4 discloses a reported sale of 27 shares at $356.05 and continuing indirect beneficial ownership of 1,248 shares held via a trust. The filing also notes an August 1, 2025 inheritance of 27 shares that was treated as exempt under applicable rules. These volumes are small relative to UnitedHealth Group's market capitalization and do not present new information about company operations or governance. The filing complies with Section 16 disclosure requirements and identifies the reporting person as a director.

Corporate Governance Expert

TL;DR: Disclosure fulfills Section 16 reporting for a director; reported indirect holdings are documented and an inheritance exemption is noted.

The Form 4 clearly identifies the reporting person, relationship to the issuer (director), transaction dates, transaction code, price, and the nature of indirect ownership (by trust). The explanatory note that the August 1, 2025 inheritance was exempt under Rules 16a-3 and 16b-5 provides the legal basis for the exemption claim. From a governance and compliance perspective, the filing documents the required items and is straightforward.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baker Charles D.

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		S		27(1)	D	$356.05	0	I	By Trust
Common Stock								1,248	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On August 1, 2025, the reporting person acquired indirect beneficial ownership of 27 UNH shares by means of an inheritance. This acquisition of securities was exempt from reporting pursuant to Rules 16a-3 and 16b-5 under the Securities Exchange Act of 1934, as amended.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Charles D. Baker	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Charles D. Baker report on Form 4 for UNH?

The Form 4 reports a transaction dated 09/11/2025 showing 27 shares of UNH with transaction code S at a price of $356.05.

How many UNH shares does the filing say Charles D. Baker beneficially owns?

The filing reports 1,248 shares of Common Stock beneficially owned indirectly by trust following the reported transaction.

What reason does the filer give for the August 1, 2025 share acquisition?

The filing states that on 08/01/2025 the reporting person acquired indirect beneficial ownership of 27 UNH shares by inheritance, and that acquisition was exempt from reporting under Rules 16a-3 and 16b-5.

What is the reporting person’s relationship to UnitedHealth Group in this filing?

The filing identifies Charles D. Baker as a director of UnitedHealth Group Inc.

When was the Form 4 signed and by whom as attorney-in-fact?

The signature block shows Faraz A. Choudhry, Attorney-in-Fact for Charles D. Baker with a signature date of 09/15/2025.